CS MEDICA A/S: CS MEDICA revises financial targets
CS MEDICA (”CS MEDICA” or the ”Company”) announces today that due to delays from the COVID-19 lockdown, the Company’s revenue goal for the coming three financial years has been revised. The revenue goal for the year 2021/2022 is reduced to DKK 12 million from previously DKK 50 million. The revenue goal for the following financial year, 2022/2023, will be adjusted to DKK 65 million from previously DKK 150 million. The revenue goal of DKK 150 million is sought to be accomplished in the financial year 2023/2024.Due to significant delays in the different business areas of CS MEDICA caused by